New study finds publication bias among trials submitted to FDA
Tuesday, November 25, 2008 - 06:28
in Health & Medicine
A quarter of drug trials submitted in support of new drug applications to the US Food and Drug Administration (FDA) remain unpublished five years after the fact, says new research published in the open access journal PLoS Medicine.